USE OF 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS

(19)

(11)

EP 1 011 689 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	09.05.2007 Bulletin 2007/19

(45)	Mention of the grant of the patent:
	31.01.2007 Bulletin 2007/05

(21)	Application number: 98945912.8

(22)	Date of filing: 04.09.1998

(51)

International Patent Classification (IPC):

A61K 31/70^(2006.01)

A61P 31/04^(2006.01)

(86)	International application number:
	PCT/US1998/018579

(87)	International publication number:
	WO 1999/012552 (18.03.1999 Gazette 1999/11)

(54)	USE OF 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS VERWENDUNG VON 9A-AZALIDEN ALS ANTIMIKROBIELLE MITTEL FÜR TIERE UTILISATION DE 9a-AZALIDES COMME AGENTS ANTIMICROBIENS VETERINAIRES

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

(30)

Priority:

10.09.1997 US 58330 P
25.03.1998 GB 9806420

(43)	Date of publication of application:
	28.06.2000 Bulletin 2000/26

(60)	Divisional application:
	06024015.7
	06026451.2
	07001854.4 / 1779853

(73)	Proprietor: Merial Ltd.
	Duluth, GA 30096 (US)

(72)	Inventors:
	KROPP, Helmut Rahway, NJ 07065 (US) FARRINGTON, Daniel, O. Rahway, NJ 07065 (US) CLARK, Jeffrey, N. Rahway, NJ 07065 (US) RATCLIFFE, Ronald, W. Rahway, NJ 07065 (US) WILKENING, Robert, D. Rahway, NJ 07065 (US)

(74)	Representative: Clyde-Watson, Zöe et al
	D Young & Co 120 Holborn London EC1N 2DY London EC1N 2DY (GB)

(56)

References cited: :

EP-A2- 0 992 509
WO-A1-98/56801
US-A- 4 328 334
US-A- 5 332 807

WO-A1-94/15617
WO-A1-98/56802
US-A- 4 526 889

MCFARLAND ET AL.: "Repromicin Derivatives with Potent Antibacterial Activity against Pasteurella multocida" J. MED. CHEM., vol. 40, 14 March 1997 (1997-03-14), pages 1041-1045,
SATOSHI OMURA: "Macrolide Antibiotics - Chemistry, Biology, and Practice" 1984, ACADEMIC PRESS, INC. * page 301 - page 347 *
DJOKIC, S. ET AL.: "Erythromycin Series. XII. Antibacterial in vitro evaluation of 10-dihydro-10-deoxo-11-azaerythromycin A: Synthesis and structure-activity relationship of its acyl derivatives" J. ANTIBIOTICS, vol. XL, no. 7, 1987, pages 1006-1015,

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).